These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15879429)

  • 1. Fluticasone reduces CRP in COPD.
    Virchow JC
    Am J Respir Crit Care Med; 2005 May; 171(10):1191; author reply 1191-2. PubMed ID: 15879429
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic bioavailability of fluticasone in COPD.
    Lipworth BJ; Menzies D
    Am J Respir Crit Care Med; 2005 May; 171(10):1191; author reply 1191-2. PubMed ID: 15879430
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease.
    Sin DD; Lacy P; York E; Man SF
    Am J Respir Crit Care Med; 2004 Oct; 170(7):760-5. PubMed ID: 15229100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease.
    Man SF; Sin DD
    Proc Am Thorac Soc; 2005; 2(1):78-82. PubMed ID: 16113473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol/fluticasone treatment reduces circulating C-reactive protein level in patients with stable chronic obstructive pulmonary disease.
    Tang YJ; Wang K; Yuan T; Qiu T; Xiao J; Yi Q; Feng YL
    Chin Med J (Engl); 2010 Jul; 123(13):1652-7. PubMed ID: 20819623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
    Sin DD; Man SF; Marciniuk DD; Ford G; FitzGerald M; Wong E; York E; Mainra RR; Ramesh W; Melenka LS; Wilde E; Cowie RL; Williams D; Gan WQ; Rousseau R;
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1207-14. PubMed ID: 18310480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of inhaled fluticasone propionate in moderate to severe COPD.
    Thompson WH; Carvalho P; Souza JP; Charan NB
    Lung; 2002; 180(4):191-201. PubMed ID: 12391509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.
    Johnson M; Agusti AG; Barnes NC
    COPD; 2008 Dec; 5(6):369-75. PubMed ID: 19353351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD.
    Perng DW; Tao CW; Su KC; Tsai CC; Liu LY; Lee YC
    Eur Respir J; 2009 Apr; 33(4):778-84. PubMed ID: 19129278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
    Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Yates JC; Vestbo J;
    N Engl J Med; 2007 Feb; 356(8):775-89. PubMed ID: 17314337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
    Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
    Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled glucocorticosteroids and chronic obstructive pulmonary disease: how full is the glass?
    Pauwels R
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1579-80. PubMed ID: 12070055
    [No Abstract]   [Full Text] [Related]  

  • 14. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.
    Justo D; Lachmi S; Saar N; Joffe E; Atzmony L; Mashav N; Henis O; Sade B; Chundadze T; Steinvil A; Paran Y
    Eur J Intern Med; 2009 Sep; 20(5):518-21. PubMed ID: 19712857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic obstructive pulmonary disease. No increased survival with combination therapy].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 2007 Nov; 30(11):428-9. PubMed ID: 18062342
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COPD: don't use fluticasone + salmeterol. Patients treated with inhaled fluticasone for chronic obstructive pulmonary disease (COPD) are more prone to pneumonia.
    Prescrire Int; 2007 Dec; 16(92):257-8. PubMed ID: 18092426
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
    Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK;
    Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence.
    Young RP; Hopkins R; Eaton TE
    Postgrad Med J; 2009 Aug; 85(1006):414-21. PubMed ID: 19633007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.